Our purpose is to provide products and services to improve the quality of life of people. We use science and technology to address existing healthcare issues.
Yuyu has been exporting products to Southeast Asia and South America since 1998. In 2016, we exported $1 million for the first time and won the $1 million export award. We also opened offices in Malaysia and Japan to expand our business reach.
Developing overseas markets and increasing exports
The main export products are Bonkey (calcitriol), which is effective in managing hypocalcemia in chronic kidney dialysis patients, Maxmarvil (alendronate sodium hydrate + calcitriol) for osteoporosis, and Yuhelix soft capsule (dutar esteride) for BPH patients. In particular, Yuyu developed and launched Vinapolo, the first soft capsule formulation in Korea in 1965, and has accumulated know-how for more than half a century in soft capsule formulation. In addition, it is a company that is ready to provide various solutions through the development of various formulations and diversification of packaging materials to satisfy market changes and consumer needs.
Global Standardization Strategy
Yuyu's export strategy is to organize R&D and production systems to meet the global standards. We are conducting strategic and active overseas marketing with partners worldwide
Yuyu GLOBAL NETWORK
Yuyu continues to seek technology partnership and joint venture with European companies and around the world. We strive to develop improved products and technology.